TUCSON, Ariz., Feb. 21, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that TJ Johnson, Chief Executive Officer, will present a corporate overview at the Cowen & Company 39th Annual Health Care Conference, being held in Boston, Mass. on March 11 – 13, 2019.
| HTG Molecular Presentation Details | ||
| Date: | Monday, March 11 | |
| Time: | 4:10 p.m. Eastern Time | |
| Location: | Boston Marriott Copley Place, Boston, MA | |
| Webcast: | http://wsw.com/webcast/cowen52/htgm/ | |
| About HTG: |
| HTG is focused on advancing precision medicine. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG’s customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options. |
Contact:
Ashley R. Robinson
LifeSci Advisors, LLC
Phone: (617) 535-7742
Email: arr@lifesciadvisors.com
Shaun McMeans
Chief Financial Officer
HTG Molecular Diagnostics, Inc.
Email: smcmeans@htgmolecular.com